CBD and THC Combination Kills Ovarian Cancer Cells More Effectively Than Either Alone
Lab experiments found that combining CBD and THC at a 3:1 ratio was more effective at killing ovarian cancer cells than either cannabinoid alone, working through apoptosis and autophagy pathways.
Quick Facts
What This Study Found
CBD:THC at a 3:1 ratio showed synergistic cytotoxicity against ovarian cancer cell lines. The combination induced apoptosis (programmed cell death) and autophagy at lower concentrations than either compound alone. CBD alone was more cytotoxic than THC alone. The combination also reduced cell migration.
Key Numbers
Optimal ratio: 3:1 CBD:THC. Synergistic cytotoxicity confirmed. Apoptosis and autophagy both activated. Cell migration reduced.
How They Did This
In vitro study testing CBD, THC, and combinations at various ratios against multiple ovarian cancer cell lines. MTT viability assays, flow cytometry for apoptosis, western blot for autophagy markers, and wound healing assays for migration.
Why This Research Matters
Ovarian cancer has limited treatment options and high mortality. The synergistic effect of CBD:THC combinations suggests cannabinoids could be explored as adjunct therapies, potentially allowing lower doses of each compound.
The Bigger Picture
The "entourage effect" — cannabinoids working better together — is often discussed anecdotally. This study provides mechanistic evidence for synergy in a specific cancer model, supporting the rationale for combination cannabinoid therapies in oncology research.
What This Study Doesn't Tell Us
In vitro only — cancer cells in a dish may not reflect tumor behavior in the body. Specific cell lines may not represent all ovarian cancers. Bioavailability and achievable tissue concentrations not addressed.
Questions This Raises
- ?Would CBD:THC combinations show similar synergy in animal ovarian cancer models?
- ?Could this ratio inform clinical trial design for cannabinoid adjunct therapy?
Trust & Context
- Key Stat:
- Evidence Grade:
- Well-designed in vitro study with multiple assays confirming mechanism, but lab-only results have a long road to clinical relevance.
- Study Age:
- 2025 preclinical study on cannabinoid combinations against ovarian cancer cells.
- Original Title:
- Selective anti-cancer effects of cannabidiol and Δ9-tetrahydrocannabinol via PI3K/AKT/mTOR inhibition and PTEN restoration in ovarian cancer cells.
- Published In:
- Frontiers in pharmacology, 16, 1693129 (2025)
- Authors:
- Tong, Siyao, Loilome, Watcharin, Namwat, Nisana, Klanrit, Poramate, Wangwiwatsin, Arporn, Win, Zar Zar, Koyabuth, Preeya, Chumworathayi, Bandit
- Database ID:
- RTHC-07810
Evidence Hierarchy
Frequently Asked Questions
Can CBD and THC kill cancer cells?
In this lab study, both CBD and THC killed ovarian cancer cells, and a 3:1 CBD:THC combination was more effective than either alone. This has not been tested in human patients.
Is combining CBD and THC better for cancer?
This study found synergistic effects at a 3:1 CBD:THC ratio against ovarian cancer cells in the lab, supporting the concept that cannabinoid combinations may be more effective than single compounds.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-07810APA
Tong, Siyao; Loilome, Watcharin; Namwat, Nisana; Klanrit, Poramate; Wangwiwatsin, Arporn; Win, Zar Zar; Koyabuth, Preeya; Chumworathayi, Bandit. (2025). Selective anti-cancer effects of cannabidiol and Δ9-tetrahydrocannabinol via PI3K/AKT/mTOR inhibition and PTEN restoration in ovarian cancer cells.. Frontiers in pharmacology, 16, 1693129. https://doi.org/10.3389/fphar.2025.1693129
MLA
Tong, Siyao, et al. "Selective anti-cancer effects of cannabidiol and Δ9-tetrahydrocannabinol via PI3K/AKT/mTOR inhibition and PTEN restoration in ovarian cancer cells.." Frontiers in pharmacology, 2025. https://doi.org/10.3389/fphar.2025.1693129
RethinkTHC
RethinkTHC Research Database. "Selective anti-cancer effects of cannabidiol and Δ9-tetrahyd..." RTHC-07810. Retrieved from https://rethinkthc.com/research/tong-2025-selective-anticancer-effects-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.